Qingsong Pang
Overview
Explore the profile of Qingsong Pang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
1548
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Huang H, Zhao G, Wang T, You Y, Zhang T, Chen X, et al.
Cancer Lett
. 2024 Aug;
601:217178.
PMID: 39142497
Tertiary lymphoid structures (TLSs) were associated with survival in esophageal squamous cell carcinoma (ESCC) undergoing surgery alone (SA). However, their clinical relevance in neoadjuvant therapies remains less known. Here, we...
12.
Duan X, Zhao F, Shang X, Yue J, Chen C, Ma Z, et al.
Cancer Med
. 2024 Aug;
13(15):e70113.
PMID: 39136674
Introduction: The chemotherapy and immunotherapy combination is currently the primary strategy to treat metastatic esophageal squamous cell carcinoma (ESCC). Neoadjuvant chemoimmunotherapy (NCIT) is being intensively investigated for treating locally advanced...
13.
Zhou Q, Pan Y, Yang X, Zhao Y, Han G, Pang Q, et al.
Cancer Cell
. 2024 Jun;
42(7):1258-1267.e2.
PMID: 38906157
We conducted a proof-of-concept, phase 2 trial to assess neoadjuvant SHR-1701 with or without chemotherapy, followed by surgery or radiotherapy, and then consolidation SHR-1701 in unresectable stage III non-small-cell lung...
14.
Li C, Chang X, Wang Q, Pang Q, Xiao Z, Zhang W, et al.
Ther Adv Med Oncol
. 2024 Jun;
16:17588359241261009.
PMID: 38882446
Background: Age is a known prognostic factor for various cancers. However, few studies explored the association between age and prognosis of esophageal cancer (EC) comprehensively, especially from a nonlinear perspective....
15.
Wang Y, Wu Y, Zheng C, Li Q, Jiao W, Wang J, et al.
BMC Gastroenterol
. 2024 May;
24(1):156.
PMID: 38720257
Background: Mucoepidermoid Carcinoma of the Esophagus (MECE) is a relatively rare tumor type, with most of the current data derived from case reports or small sample studies. This retrospective study...
16.
Lv X, Wu Y, Li Q, Zheng C, Lin Q, Pang Q, et al.
Strahlenther Onkol
. 2024 Jan;
200(10):857-866.
PMID: 38267589
Purpose: This study aims to evaluate the risk factors of treatment-related pneumonitis (TRP) following thoracic radiotherapy/chemoradiotherapy combined with anti-PD‑1 monoclonal antibodies (mAbs) in patients with advanced esophageal squamous cell carcinoma...
17.
Zhang K, Zhang T, Guo Z, Zhao F, Li J, Li Y, et al.
BMC Cancer
. 2023 Dec;
23(1):1240.
PMID: 38104068
Background: Brain metastases (BMs) are the most frequent intracranial tumours associated with poor clinical outcomes. Radiotherapy is essential in the treatment of these tumours, although the optimal radiation strategy remains...
18.
Du Q, Wu X, Zhang K, Cao F, Zhao G, Wei X, et al.
BMC Cancer
. 2023 Jul;
23(1):697.
PMID: 37491217
No abstract available.
19.
Du Q, Wu X, Zhang K, Cao F, Zhao G, Wei X, et al.
BMC Cancer
. 2023 Jul;
23(1):681.
PMID: 37474893
Introduction: Endoscopic ultrasound (EUS) may play a role in evaluating treatment response after definitive chemoradiation therapy (dCRT) for esophageal squamous cell carcinoma (ESCC). This study explored the prognostic markers of...
20.
Yan C, Huang H, Zheng Z, Ma X, Zhao G, Zhang T, et al.
Front Immunol
. 2023 Jun;
14:1138054.
PMID: 37275884
Background: The spatial distribution of tumor-infiltrating T cells and its dynamics during chemoradiotherapy combined with PD-1 blockade is little known in esophageal squamous cell carcinoma (ESCC). Methods: We applied the...